Business units

The Onco & Hospital business unit focuses on complex specialty therapies and hospital-based treatment solutions. Operating in highly specialized healthcare environments, the team works closely with hospitals, oncology centers, healthcare professionals, and national institutions to support market access, clinical engagement, and sustainable treatment availability.

Our experience includes navigating complex reimbursement pathways, stakeholder coordination, and product commercialization within hospital and specialty care segments.

The RX business unit manages prescription medicines across a broad range of therapeutic areas. Combining local market expertise with strong commercial execution, the team supports product positioning, healthcare professional engagement, and long-term portfolio growth across regional markets.

The unit works closely with physicians, pharmacies, and healthcare stakeholders to ensure effective product communication and sustainable market development.

The OTC business unit focuses on consumer healthcare products designed for everyday health and well-being. The team develops locally adapted brand and communication strategies that combine scientific credibility with consumer engagement across both traditional and digital channels.

By closely monitoring market trends and consumer behavior, the unit supports sustainable brand growth and strong market visibility.

The Rare Diseases business unit is dedicated to therapies addressing unmet medical needs and highly specialized patient populations. These products often require individualized market access strategies, close collaboration with healthcare professionals, and deep understanding of patient pathways within each market.

The team works alongside physicians, patient organizations, and institutions to support earlier diagnosis, patient identification, and sustainable access to innovative therapies.